• CARMIL Membrane Binding in Actin Assembly

  2026-09-07

  This bioRxiv preprint identifies the CARMIL membrane-binding domain as an active regulator of capping protein, rather than a passive membrane tether. Its central finding is that the domain can recruit CARMIL and capping protein to lipid surfaces, then dissociate after capping protein binding to promote uncapping and soluble activation.

• Cell Counting Kit-8 (CCK-8): Reliable Assays

  2026-09-05

  This scenario-based guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, supports reproducible cell viability, proliferation, and cytotoxicity measurements. It connects WST-8 assay principles with practical controls, optimization, interpretation, and vendor-selection decisions in biomedical research.

• Sodium Ascorbate: Redox Assays and Biomarker Logic

  2026-09-04

  Sodium Ascorbate can be more than a ROS-inducing reagent: it can serve as a controlled perturbation for studying tumor-cell injury and assay design. This article connects mineral-salt chemistry, glioblastoma multiforme research, and the biomarker architecture of modern immunotherapy studies.

• Trelagliptin, PI-3K/AKT, and Adipocyte Insulin Resistance

  2026-09-04

  The reference study links trelagliptin succinate to improved insulin responsiveness in differentiated 3T3-L1 adipocytes through coordinated changes in IRS-1, AKT, GLUT4, and adipokine-related readouts. Its main practical value is a cell-based framework for connecting DPP-4 inhibition with adipocyte glucose handling while highlighting the need for careful phosphoprotein preservation and mechanistic controls.

• Structure-Guided Design of Tomivosertib for MNK1/2

  2026-09-04

  The reference study describes how crystal structure-guided medicinal chemistry produced eFT508, also known as Tomivosertib, as a potent and highly selective dual MNK1/2 inhibitor. By suppressing MNK-dependent eIF4E phosphorylation, the compound demonstrated antitumor activity in lymphoma and solid-tumor models while illustrating how dysregulated translation can be targeted without broadly blocking protein synthesis.

• BRD4 Inhibition Amplifies Erastin-Induced Ferroptosis

  2026-09-03

  The reference study shows that pharmacological or genetic BRD4 inhibition sensitizes multiple cell lines to erastin-induced ferroptosis through a shared increase in reactive oxygen species and suppression of FSP1. Its combination of broad cell-line testing, BRD4 knockdown, and promoter-occupancy analysis provides a mechanistic framework for evaluating BET inhibitors in ferroptosis-oriented cancer biology research.

• Ruxolitinib phosphate: JAK/STAT Workflow Guide

  2026-09-02

  Ruxolitinib phosphate, also known as INCB018424, supports controlled studies of JAK1/2-dependent cytokine signaling, inflammatory phenotypes, and tumor-cell death. This workflow translates the reported JAK1/2-STAT3-DRP1 mechanism in anaplastic thyroid cancer into practical assay design, dosing, controls, and troubleshooting.

• HyperFluor 488 Goat Anti-Mouse IgG Workflow

  2026-09-02

  Build a reproducible fluorescence workflow for radiation-injured endothelial models with a high-sensitivity, fluorescently labeled secondary antibody. This guide connects tube formation, DNA-damage, immunofluorescence, flow cytometry, and western blot readouts while separating literature findings from practical optimization.

• Ionizing Radiation and Altered Neuronal Differentiation

  2026-09-01

  The reference study shows that ionizing radiation can redirect neuronal differentiation in C17.2 mouse neural stem-like cells rather than simply depleting neural precursor populations. Its experiments connect increased neurite outgrowth and altered neurotransmitter-related gene expression to PI3K-STAT3-mGluR1 and PI3K-p53 signaling, providing a mechanistic framework for studying radiation-associated neural dysfunction.

• SAG Protects Frataxin-Deficient Astrocytes

  2026-09-01

  Vicente-Acosta et al. showed that frataxin depletion drives mitochondrial stress, reactive astrocyte features, and neuron-damaging secretory activity in cultured human astrocytes. Chronic Smoothened receptor agonist treatment with SAG prevented many of these abnormalities, supporting Hedgehog pathway activation as a strategy for studying astrocyte-mediated neurodegeneration in Friedreich’s ataxia.

• IGFBP2–THBS1 Axis in GH Therapy for Short Stature

  2026-08-31

  The reference study identifies an IGFBP2–THBS1 regulatory axis that connects growth hormone treatment with IGF-1 signaling, chondrocyte proliferation, and hypertrophic differentiation in idiopathic short stature. Its combination of patient plasma data, bioinformatic prediction, and gain- and loss-of-function experiments provides a mechanistic framework for understanding variable responses to growth hormone therapy.

• Griseofulvin Microtubule Assay Workflow

  2026-08-31

  Build a practical Griseofulvin workflow that connects fungal growth inhibition with microtubule mechanism profiling. The approach combines formulation control, time-resolved phenotyping, and a reference-informed flow-cytometry strategy to distinguish microtubule effects from general cellular stress.

• TP53, ATM, and MDM2 Shape Calicheamicin Response

  2026-08-30

  This study uses genome-wide CRISPR/Cas9 screening and targeted validation to define DNA damage-response genes that regulate calicheamicin sensitivity in acute leukemia. TP53 loss markedly reduced calicheamicin activity, whereas MDM2 and ATM inhibition enhanced cytotoxicity through partly distinct mechanisms, suggesting biomarker-guided combinations for gemtuzumab ozogamicin and inotuzumab ozogamicin research.

• SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-29

  This Cell Stem Cell study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like organoids to model neural regulation of pacemaker activity. Integration with human SAN spatial transcriptomics identifies a prosaposin–GPR37 signaling axis associated with pacemaker maturation and establishes a functional platform for studying conduction disorders.

• From Barrier Biology to Better Biotin Imaging

  2026-08-28

  Biohybrid microrobots may improve access to difficult tumor environments, but translational progress depends on proving where these systems travel and what they engage. This thought-leadership article connects the deformable, magnetically guided Euglena gracilis platform reported in Microsystems & Nanoengineering with Streptavidin-Cy3 as a modular fluorescent readout for biotinylated targets across tissue imaging, nucleic-acid detection, and flow cytometry.

8084 records 1/539 page Next 12345 下5页 Last page